AstraZeneca CEO says AI is changing drug development and helping increase chances of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…
CNBC's Jim Cramer said Thursday that investors should look beyond the market's hottest trades and start looking for opportunities in…
A drone view shows the Eli Lilly logo at the company's office in San Diego, California, on November 21, 2025.…
A startup widely known as “ChatGPT for doctors” raised a new round of funding that values the company at $12…
President Donald Trump's decision Thursday to sign an executive order easing federal restrictions on marijuana (and clearing the way for…
US President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, DC,…
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on US President Joe Biden “to…
Citigroup believes investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the…
Wall Street is optimistic that Olema Pharmaceuticals could be developing the next big breakthrough in breast cancer treatment. Earlier this…
It's been a stellar few months for the San Francisco-based biotech company's stock Rigel Pharmaceuticalswhich has approved treatments for hematology…